Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis-Reference-Cited by-同舟云学术

Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis

Published:2023-09 Issue:9 Volume:11 Page:782-790
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Winters Nicholas,Belknap Robert,Benedetti Andrea,Borisov Andrey,Campbell Jonathon R,Chaisson Richard E,Chan Pei-Chun,Martinson Neil,Nahid Payam,Scott Nigel A,Sizemore Erin,Sterling Timothy R,Villarino M Elsa,Wang Jann-Yuan,Menzies Dick

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference33 articles.

1. Global tuberculosis report 2022,2022

2. WHO operational handbook on tuberculosis. Module 1: prevention – tuberculosis preventive treatment,2020

3. Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention;Reid;Int J Tuberc Lung Dis,2015

4. WHO's new End TB Strategy;Uplekar;Lancet,2015

5. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies;Tiberi;Lancet Infect Dis,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with incomplete tuberculosis preventive treatment: a retrospective analysis of six-years programmatic data in Cambodia;Scientific Reports;2024-08-09

2. Factors associated with incomplete tuberculosis preventive treatment: A retrospective analysis of six-years programmatic data in Cambodia;2024-06-17

3. Mixed methods study on latent tuberculosis among agate stone workers and advocacy for testing silica dust exposed individuals in India;Scientific Reports;2024-06-15

4. High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial;The Lancet Respiratory Medicine;2024-06

5. The 3 HP regimen for tuberculosis preventive treatment: safety, dosage and related concerns during its large-scale implementation in countries like India;The Lancet Regional Health - Southeast Asia;2024-05